Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19
CompletedOBSERVATIONAL
Enrollment
921
Participants
Timeline
Start Date
July 21, 2020
Primary Completion Date
August 27, 2020
Study Completion Date
August 27, 2020
Conditions
Inflammatory DiseaseCovid19
Trial Locations (1)
59037
Hop Claude Huriez Chu Lille, Lille
All Listed Sponsors
lead
University Hospital, Lille
OTHER
NCT04513561 - Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19 | Biotech Hunter | Biotech Hunter